InfuSystem Holdings (INFU) EBITDA Margin (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly EBITDA Margin came in at 11.24% in Q2 2026, up 75.0% on a YoY basis from 6.42% in Q2 2025, and up 138.16% quarter-over-quarter from 4.72% in Q1 2026.
Powered by 
Analysis
InfuSystem Holdings (INFU) EBITDA Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has reported EBITDA Margin for 17 consecutive years, with 11.24% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin rose 75.0% year-over-year to 11.24%; the trailing twelve-month figure through Jun 2026 stood at 9.26% (up 191.0% YoY), and the FY2025 full-year result was 8.31%, up 320.0% from the prior year.
- EBITDA Margin climbed to 11.24% in Q2 2026 per INFU's latest filing, from 4.72% in the prior quarter.
- Across five years, EBITDA Margin topped out at 11.24% in Q2 2026 and bottomed at 2.64% in Q1 2024.
- Historically, EBITDA Margin has averaged 4.86% across 5 years, with a median of 4.33% in 2026.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin tumbled 553 bps in 2022, then surged 499 bps in 2025.
- Over 5 years, EBITDA Margin stood at 3.57% in 2022, then increased by 10 bps to 3.93% in 2023, then soared by 96 bps to 7.73% in 2024, then jumped by 33 bps to 10.25% in 2025, then rose by 10 bps to 11.24% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 11.24%, 4.72%, and 10.25% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 16.29% |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | 6.34% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 9.58% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 18.99% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 1.88% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.75 Bn | - | 11.67% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 11.41% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 12.03% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 10.25% |
| 10 | InfuSystem Holdings | 242.76 Mn | 241.80 Mn | 21.41 Mn | 11.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.24% |
| Mar 31, 2026 | 4.72% |
| Dec 31, 2025 | 10.25% |
| Sep 30, 2025 | 10.44% |
| Jun 30, 2025 | 10.49% |
| Mar 31, 2025 | 1.78% |
| Dec 31, 2024 | 7.73% |
| Sep 30, 2024 | 9.24% |
| Jun 30, 2024 | 5.50% |
| Mar 31, 2024 | -2.64% |
| Dec 31, 2023 | 3.93% |
| Sep 30, 2023 | 5.32% |
| Jun 30, 2023 | 3.93% |
| Mar 31, 2023 | -0.35% |
| Dec 31, 2022 | 3.57% |
| Sep 30, 2022 | 3.46% |
| Jun 30, 2022 | 0.77% |
| Mar 31, 2022 | -1.96% |
| Dec 31, 2021 | 6.04% |
| Sep 30, 2021 | -1.32% |